David Patience was appointed Chief Financial Officer beginning in July 2025.
David has nearly 20 years of experience as a financial executive across healthcare and financial services. Prior to TriSalus, David served as Chief Financial Officer at Accelerate Diagnostics. David brings a strong leadership track record within financial operations, strategic portfolio planning, capital markets and commercial operations. Previously, he has held positions at Morgan Stanley’s Investment Banking Division, Continental Advisors equity group, and various financial research roles at Nuveen Investments.
David received his Bachelor of Science in Business Administration from the University of Colorado Leeds School of Business and an MBA from the University of Chicago Booth School of Business.
